Opinion
Video
Author(s):
Ronald Oudiz, MD, FACP, FACC, FCCP, discusses the challenges and limitations associated with the adoption of new treatments and the impact of emerging therapies on patient outcomes, quality of life, and disease management in the long term.
Video content above is prompted by the following questions:
Refinements to European Strategy Can Improve PAH-CHD Stratification